Novel Drugs for Geriatric Patients

Creative Commons License

Barış E., Tunçok Y.

Geriatric Pharmacology and Pharmacotherapy - 2023, Prof. Dr. Canan ULUOĞLU,Prof. Dr. Aylin ARICI,Doç. Dr. Volkan AYDIN, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.55-59, 2023

  • Yayın Türü: Kitapta Bölüm / Mesleki Kitap
  • Basım Tarihi: 2023
  • Yayınevi: Türkiye Klinikleri Yayınevi
  • Basıldığı Şehir: Ankara
  • Sayfa Sayıları: ss.55-59
  • Editörler: Prof. Dr. Canan ULUOĞLU,Prof. Dr. Aylin ARICI,Doç. Dr. Volkan AYDIN, Editör
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

While the global population of individuals aged 65 and older is projected to surpass 80 million by 2050, this situation highlights the need for personalized and accessible elderly care. This projection intersects with the demand for advanced treatments that enhance both longevity and quality of life, and prevalent chronic diseases in geriatric patients bring along high-cost treatments. This article addresses novel drugs used in treatment of chronic diseases in geriatric patients, including recently approved medications, lecanemab, aducanumab, edoxaban, and evolocumab.

Keywords: Geriatrics; aducanumab; edoxaban; evolocumab; lecanemab